{"id":"VC0148","type":"news","title":"AI-Driven Precision Oncology Startup aiPTO Unveils #1-Ranked DELPHAI Model, Bridging the \"Scale Gap\" From Virtual Cells to Virtual Tumors","authors_or_org":"aiPTO TechBio (Business Wire press release)","date":"2026-10-08","year":"2026","venue":"Business Wire","url":"https://www.businesswire.com/news/home/20261008324150/en/AI-Driven-Precision-Oncology-Startup-aiPTO-Unveils-1-Ranked-DELPHAI-Model-Bridging-the-Scale-Gap-From-Virtual-Cells-to-Virtual-Tumors","doi":"","pmid":"","brain_tumor_focus":"yes","tags":["news","perturbation","virtual-tumor","organoid","platform"],"tag_slugs":["news","perturbation","digital-twin","organoid","platform"],"tag_labels":["News","Perturbation","Digital twin","Organoid","Platform"],"tag_labels_zh":["新闻","扰动","数字孪生","类器官","平台"],"unmapped_tags":[],"one_line_summary_en":"Company press release, single-party claim, pending independent verification (not evidence of model performance). The release states that DELPHAI achieved the #1 ranking on differentially expressed gene recovery in two benchmarking frameworks (Wei et al., Nat Methods 2026, DOI 10.1038/s41592-025-02980-0; Radig et al., Genome Biol 2026, DOI 10.1186/s13059-026-04104-z), describes a 'Fitness Gating' mechanism, and says the company's IPTO organoid platform covers 500+ patients across 40+ CNS tumor subtypes (company figure). No numerical results are given; training on IPTO data is described as in progress. Relates to VC0147.","one_line_summary_zh":"公司新闻稿，单方声明，有待独立核实（并非模型性能的证据）。稿件称 DELPHAI 在两个基准评测框架（Wei 等，Nat Methods 2026，DOI 10.1038/s41592-025-02980-0；Radig 等，Genome Biol 2026，DOI 10.1186/s13059-026-04104-z）中差异表达基因恢复排名第一，介绍“Fitness Gating”机制，并称其 IPTO 类器官平台涵盖 500+ 名患者、40+ 种中枢神经系统肿瘤亚型（公司自述数字）。稿中未给出任何数值结果；基于 IPTO 数据的训练被描述为“正在进行”。关联 VC0147。","verified":"yes","verification_source":"Business Wire release URL (date 20261008 in URL; full text read via TMCnet syndicated copy dated 2026-10-08; businesswire.com page itself not retrievable by our tools)","page_url":"https://gliostate.com/library/VC0148/","api_url":"https://gliostate.com/api/items/VC0148.json","sameAs":["https://www.businesswire.com/news/home/20261008324150/en/AI-Driven-Precision-Oncology-Startup-aiPTO-Unveils-1-Ranked-DELPHAI-Model-Bridging-the-Scale-Gap-From-Virtual-Cells-to-Virtual-Tumors"],"is_preprint":false,"facets":{"type":"https://gliostate.com/library/type/news/","year":"https://gliostate.com/library/year/2026/","tags":["https://gliostate.com/library/tag/news/","https://gliostate.com/library/tag/perturbation/","https://gliostate.com/library/tag/digital-twin/","https://gliostate.com/library/tag/organoid/","https://gliostate.com/library/tag/platform/"]},"cited_by":[],"related":[{"id":"VC0108","title":"Xaira's first virtual cell model is largest to-date","shared_tags":["news"],"page_url":"https://gliostate.com/library/VC0108/","api_url":"https://gliostate.com/api/items/VC0108.json"},{"id":"VC0106","title":"NeurIPS 2025: Altos Labs wins Generalist Prize at Arc's Virtual Cell Challenge","shared_tags":["news"],"page_url":"https://gliostate.com/library/VC0106/","api_url":"https://gliostate.com/api/items/VC0106.json"},{"id":"VC0007","title":"Can AI build a virtual cell? Scientists race to model life's smallest unit.","shared_tags":["news"],"page_url":"https://gliostate.com/library/VC0007/","api_url":"https://gliostate.com/api/items/VC0007.json"},{"id":"VC0043","title":"CZ CELLxGENE Discover: a single-cell data platform for scalable exploration, analysis and modeling of aggregated data.","shared_tags":["platform"],"page_url":"https://gliostate.com/library/VC0043/","api_url":"https://gliostate.com/api/items/VC0043.json"},{"id":"VC0100","title":"CZI Virtual Cells Platform","shared_tags":["platform"],"page_url":"https://gliostate.com/library/VC0100/","api_url":"https://gliostate.com/api/items/VC0100.json"},{"id":"VC0103","title":"Arc Institute Virtual Cell Initiative","shared_tags":["platform"],"page_url":"https://gliostate.com/library/VC0103/","api_url":"https://gliostate.com/api/items/VC0103.json"}]}